Matches in Wikidata for { <http://www.wikidata.org/entity/Q58546683> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q58546683 description "artículu científicu espublizáu en payares de 2018" @default.
- Q58546683 description "bài báo khoa học" @default.
- Q58546683 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58546683 description "scientific article published on 01 November 2018" @default.
- Q58546683 description "wetenschappelijk artikel" @default.
- Q58546683 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q58546683 name "Correction: Phase I Dose-Escalation Study of Taselisib, an Oral PI3KInhibitor, in Patients with Advanced Solid Tumors" @default.
- Q58546683 name "Correction: Phase I Dose-Escalation Study of Taselisib, an Oral PI3KInhibitor, in Patients with Advanced Solid Tumors" @default.
- Q58546683 type Item @default.
- Q58546683 label "Correction: Phase I Dose-Escalation Study of Taselisib, an Oral PI3KInhibitor, in Patients with Advanced Solid Tumors" @default.
- Q58546683 label "Correction: Phase I Dose-Escalation Study of Taselisib, an Oral PI3KInhibitor, in Patients with Advanced Solid Tumors" @default.
- Q58546683 prefLabel "Correction: Phase I Dose-Escalation Study of Taselisib, an Oral PI3KInhibitor, in Patients with Advanced Solid Tumors" @default.
- Q58546683 prefLabel "Correction: Phase I Dose-Escalation Study of Taselisib, an Oral PI3KInhibitor, in Patients with Advanced Solid Tumors" @default.
- Q58546683 P1433 Q58546683-019B3535-B0EB-41B6-84BD-8D15298D9BA8 @default.
- Q58546683 P1476 Q58546683-1B041186-D929-4A7E-B11F-4A22783CC90A @default.
- Q58546683 P304 Q58546683-413BA912-A2A1-412C-8809-9EA46828053F @default.
- Q58546683 P31 Q58546683-98A8D5F9-EB2D-415A-923D-92D289DB3260 @default.
- Q58546683 P356 Q58546683-E6DEEA8E-94DB-4FDA-9BAC-38C6783B9C34 @default.
- Q58546683 P407 Q58546683-AA6CE850-0CEC-4E3B-8B57-E1D315366B10 @default.
- Q58546683 P433 Q58546683-7A0BAE30-04D5-47AC-A505-FCF39558AF0B @default.
- Q58546683 P478 Q58546683-2C87343B-CCAC-4348-8CAE-B1CB35A777EB @default.
- Q58546683 P577 Q58546683-3643A783-9388-4AF9-BFAD-122DFE0D46FF @default.
- Q58546683 P698 Q58546683-0B1BF3A0-C6C0-4598-AC32-EE5EA858D9D5 @default.
- Q58546683 P356 2159-8290.CD-18-1115 @default.
- Q58546683 P698 30385526 @default.
- Q58546683 P1433 Q15724440 @default.
- Q58546683 P1476 "Correction: Phase I Dose-Escalation Study of Taselisib, an Oral PI3KInhibitor, in Patients with Advanced Solid Tumors" @default.
- Q58546683 P304 "1491" @default.
- Q58546683 P31 Q13442814 @default.
- Q58546683 P356 "10.1158/2159-8290.CD-18-1115" @default.
- Q58546683 P407 Q1860 @default.
- Q58546683 P433 "11" @default.
- Q58546683 P478 "8" @default.
- Q58546683 P577 "2018-11-01T00:00:00Z" @default.
- Q58546683 P698 "30385526" @default.